Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation

Authors

  • Ozlem Guzel Tunccan Faculty of Medicine, Gazi University Ankara, Turkey
  • Sahika Zeynep Aki Faculty of Medicine, Gazi University Ankara, Turkey
  • Nalan Akyurek Faculty of Medicine, Gazi University Ankara, Turkey
  • Gulsan Sucak Faculty of Medicine, Gazi University Ankara, Turkey
  • Esin Senol Faculty of Medicine, Gazi University Ankara, Turkey

DOI:

https://doi.org/10.3855/jidc.1466

Keywords:

haematopoietic stem cell transplantation, graft versus host disease, mesenchymal stem cells, cutaneous aspergillosis

Abstract

Cutaneous aspergillosis is very rare and occurs predominantly in immunocompromised patients including transplant recipients. We report a 26-year-old male with acute lymphoblastic leukemia who developed cutaneous aspergillosis after undergoing combined immunosuppressive treatment including corticosteroid, cyclosporine A, mychophenolate mofetil and mesenchymal stem cells for steroid refractory skin acute graft versus host disease after myeloablative haematopoietic stem cell transplantation.  The patient was treated with oral voriconazole therapy and recovered partially. 

Downloads

Published

2011-03-04

How to Cite

1.
Tunccan OG, Aki SZ, Akyurek N, Sucak G, Senol E (2011) Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation. J Infect Dev Ctries 5:406–409. doi: 10.3855/jidc.1466

Issue

Section

Case Reports